COVID-19 Outbreak-Global Age Related Macular Degeneration Biologic Drug Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020
- MAI3927283
- 122 Pages
- July 2020
- Pharmaceuticals
The Age Related Macular Degeneration Biologic Drug market revenue was xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025.
Under COVID-19 outbreak globally, this report provides 360 degrees of analysis from supply chain, import and export control to regional government policy and future influence on the industry. Detailed analysis about market status (2015-2020), enterprise competition pattern, advantages and disadvantages of enterprise products, industry development trends (2020-2025), regional industrial layout characteristics and macroeconomic policies, industrial policy has also been included. From raw materials to end users of this industry are analyzed scientifically, the trends of product circulation and sales channel will be presented as well. Considering COVID-19, this report provides comprehensive and in-depth analysis on how the epidemic push this industry transformation and reform.
In COVID-19 outbreak, Chapter 2.2 of this report provides an analysis of the impact of COVID-19 on the global economy and the Age Related Macular Degeneration Biologic Drug industry.
Chapter 3.7 covers the analysis of the impact of COVID-19 from the perspective of the industry chain.
In addition, chapters 7-11 consider the impact of COVID-19 on the regional economy.
The Age Related Macular Degeneration Biologic Drug market can be split based on product types, major applications, and important countries as follows:
Key players in the global Age Related Macular Degeneration Biologic Drug market covered in Chapter 12:
Regeneron
Valeant
Novartis
Genentech
Allergan
Eli Lilly
Alimera Sciences
Merck
Acucela
Bayer
Ophthotech Corporation
In Chapter 4 and 14.1, on the basis of types, the Age Related Macular Degeneration Biologic Drug market from 2015 to 2025 is primarily split into:
Ranibizumab
Bevacizumab
Aflibercept
In Chapter 5 and 14.2, on the basis of applications, the Age Related Macular Degeneration Biologic Drug market from 2015 to 2025 covers:
Outpatient Surgery Center
Eye Clinic
Hospital
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 6, 7, 8, 9, 10, 11, 14:
North America (Covered in Chapter 7 and 14)
United States
Canada
Mexico
Europe (Covered in Chapter 8 and 14)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 9 and 14)
China
Japan
South Korea
Australia
India
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 10 and 14)
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Others
South America (Covered in Chapter 11 and 14)
Brazil
Argentina
Columbia
Chile
Others
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025
1 Age Related Macular Degeneration Biologic Drug Introduction and Market Overview
1.1 Objectives of the Study
1.2 Overview of Age Related Macular Degeneration Biologic Drug
1.3 Scope of The Study
1.3.1 Key Market Segments
1.3.2 Players Covered
1.3.3 COVID-19's impact on the Age Related Macular Degeneration Biologic Drug industry
1.4 Methodology of The Study
1.5 Research Data Source
2 Executive Summary
2.1 Market Overview
2.1.1 Global Age Related Macular Degeneration Biologic Drug Market Size, 2015 – 2020
2.1.2 Global Age Related Macular Degeneration Biologic Drug Market Size by Type, 2015 – 2020
2.1.3 Global Age Related Macular Degeneration Biologic Drug Market Size by Application, 2015 – 2020
2.1.4 Global Age Related Macular Degeneration Biologic Drug Market Size by Region, 2015 - 2025
2.2 Business Environment Analysis
2.2.1 Global COVID-19 Status and Economic Overview
2.2.2 Influence of COVID-19 Outbreak on Age Related Macular Degeneration Biologic Drug Industry Development
3 Industry Chain Analysis
3.1 Upstream Raw Material Suppliers of Age Related Macular Degeneration Biologic Drug Analysis
3.2 Major Players of Age Related Macular Degeneration Biologic Drug
3.3 Age Related Macular Degeneration Biologic Drug Manufacturing Cost Structure Analysis
3.3.1 Production Process Analysis
3.3.2 Manufacturing Cost Structure of Age Related Macular Degeneration Biologic Drug
3.3.3 Labor Cost of Age Related Macular Degeneration Biologic Drug
3.4 Market Distributors of Age Related Macular Degeneration Biologic Drug
3.5 Major Downstream Buyers of Age Related Macular Degeneration Biologic Drug Analysis
3.6 The Impact of Covid-19 From the Perspective of Industry Chain
3.7 Regional Import and Export Controls Will Exist for a Long Time
3.8 Continued downward PMI Spreads Globally
4 Global Age Related Macular Degeneration Biologic Drug Market, by Type
4.1 Global Age Related Macular Degeneration Biologic Drug Value and Market Share by Type (2015-2020)
4.2 Global Age Related Macular Degeneration Biologic Drug Production and Market Share by Type (2015-2020)
4.3 Global Age Related Macular Degeneration Biologic Drug Value and Growth Rate by Type (2015-2020)
4.3.1 Global Age Related Macular Degeneration Biologic Drug Value and Growth Rate of Ranibizumab
4.3.2 Global Age Related Macular Degeneration Biologic Drug Value and Growth Rate of Bevacizumab
4.3.3 Global Age Related Macular Degeneration Biologic Drug Value and Growth Rate of Aflibercept
4.4 Global Age Related Macular Degeneration Biologic Drug Price Analysis by Type (2015-2020)
5 Age Related Macular Degeneration Biologic Drug Market, by Application
5.1 Downstream Market Overview
5.2 Global Age Related Macular Degeneration Biologic Drug Consumption and Market Share by Application (2015-2020)
5.3 Global Age Related Macular Degeneration Biologic Drug Consumption and Growth Rate by Application (2015-2020)
5.3.1 Global Age Related Macular Degeneration Biologic Drug Consumption and Growth Rate of Outpatient Surgery Center (2015-2020)
5.3.2 Global Age Related Macular Degeneration Biologic Drug Consumption and Growth Rate of Eye Clinic (2015-2020)
5.3.3 Global Age Related Macular Degeneration Biologic Drug Consumption and Growth Rate of Hospital (2015-2020)
6 Global Age Related Macular Degeneration Biologic Drug Market Analysis by Regions
6.1 Global Age Related Macular Degeneration Biologic Drug Sales, Revenue and Market Share by Regions
6.1.1 Global Age Related Macular Degeneration Biologic Drug Sales by Regions (2015-2020)
6.1.2 Global Age Related Macular Degeneration Biologic Drug Revenue by Regions (2015-2020)
6.2 North America Age Related Macular Degeneration Biologic Drug Sales and Growth Rate (2015-2020)
6.3 Europe Age Related Macular Degeneration Biologic Drug Sales and Growth Rate (2015-2020)
6.4 Asia-Pacific Age Related Macular Degeneration Biologic Drug Sales and Growth Rate (2015-2020)
6.5 Middle East and Africa Age Related Macular Degeneration Biologic Drug Sales and Growth Rate (2015-2020)
6.6 South America Age Related Macular Degeneration Biologic Drug Sales and Growth Rate (2015-2020)
7 North America Age Related Macular Degeneration Biologic Drug Market Analysis by Countries
7.1 The Influence of COVID-19 on North America Market
7.2 North America Age Related Macular Degeneration Biologic Drug Sales, Revenue and Market Share by Countries
7.2.1 North America Age Related Macular Degeneration Biologic Drug Sales by Countries (2015-2020)
7.2.2 North America Age Related Macular Degeneration Biologic Drug Revenue by Countries (2015-2020)
7.3 United States Age Related Macular Degeneration Biologic Drug Sales and Growth Rate (2015-2020)
7.4 Canada Age Related Macular Degeneration Biologic Drug Sales and Growth Rate (2015-2020)
7.5 Mexico Age Related Macular Degeneration Biologic Drug Sales and Growth Rate (2015-2020)
8 Europe Age Related Macular Degeneration Biologic Drug Market Analysis by Countries
8.1 The Influence of COVID-19 on Europe Market
8.2 Europe Age Related Macular Degeneration Biologic Drug Sales, Revenue and Market Share by Countries
8.2.1 Europe Age Related Macular Degeneration Biologic Drug Sales by Countries (2015-2020)
8.2.2 Europe Age Related Macular Degeneration Biologic Drug Revenue by Countries (2015-2020)
8.3 Germany Age Related Macular Degeneration Biologic Drug Sales and Growth Rate (2015-2020)
8.4 UK Age Related Macular Degeneration Biologic Drug Sales and Growth Rate (2015-2020)
8.5 France Age Related Macular Degeneration Biologic Drug Sales and Growth Rate (2015-2020)
8.6 Italy Age Related Macular Degeneration Biologic Drug Sales and Growth Rate (2015-2020)
8.7 Spain Age Related Macular Degeneration Biologic Drug Sales and Growth Rate (2015-2020)
8.8 Russia Age Related Macular Degeneration Biologic Drug Sales and Growth Rate (2015-2020)
9 Asia Pacific Age Related Macular Degeneration Biologic Drug Market Analysis by Countries
9.1 The Influence of COVID-19 on Asia Pacific Market
9.2 Asia Pacific Age Related Macular Degeneration Biologic Drug Sales, Revenue and Market Share by Countries
9.2.1 Asia Pacific Age Related Macular Degeneration Biologic Drug Sales by Countries (2015-2020)
9.2.2 Asia Pacific Age Related Macular Degeneration Biologic Drug Revenue by Countries (2015-2020)
9.3 China Age Related Macular Degeneration Biologic Drug Sales and Growth Rate (2015-2020)
9.4 Japan Age Related Macular Degeneration Biologic Drug Sales and Growth Rate (2015-2020)
9.5 South Korea Age Related Macular Degeneration Biologic Drug Sales and Growth Rate (2015-2020)
9.6 India Age Related Macular Degeneration Biologic Drug Sales and Growth Rate (2015-2020)
9.7 Southeast Asia Age Related Macular Degeneration Biologic Drug Sales and Growth Rate (2015-2020)
9.8 Australia Age Related Macular Degeneration Biologic Drug Sales and Growth Rate (2015-2020)
10 Middle East and Africa Age Related Macular Degeneration Biologic Drug Market Analysis by Countries
10.1 The Influence of COVID-19 on Middle East and Africa Market
10.2 Middle East and Africa Age Related Macular Degeneration Biologic Drug Sales, Revenue and Market Share by Countries
10.2.1 Middle East and Africa Age Related Macular Degeneration Biologic Drug Sales by Countries (2015-2020)
10.2.2 Middle East and Africa Age Related Macular Degeneration Biologic Drug Revenue by Countries (2015-2020)
10.3 Saudi Arabia Age Related Macular Degeneration Biologic Drug Sales and Growth Rate (2015-2020)
10.4 UAE Age Related Macular Degeneration Biologic Drug Sales and Growth Rate (2015-2020)
10.5 Egypt Age Related Macular Degeneration Biologic Drug Sales and Growth Rate (2015-2020)
10.6 Nigeria Age Related Macular Degeneration Biologic Drug Sales and Growth Rate (2015-2020)
10.7 South Africa Age Related Macular Degeneration Biologic Drug Sales and Growth Rate (2015-2020)
11 South America Age Related Macular Degeneration Biologic Drug Market Analysis by Countries
11.1 The Influence of COVID-19 on Middle East and Africa Market
11.2 South America Age Related Macular Degeneration Biologic Drug Sales, Revenue and Market Share by Countries
11.2.1 South America Age Related Macular Degeneration Biologic Drug Sales by Countries (2015-2020)
11.2.2 South America Age Related Macular Degeneration Biologic Drug Revenue by Countries (2015-2020)
11.3 Brazil Age Related Macular Degeneration Biologic Drug Sales and Growth Rate (2015-2020)
11.4 Argentina Age Related Macular Degeneration Biologic Drug Sales and Growth Rate (2015-2020)
11.5 Columbia Age Related Macular Degeneration Biologic Drug Sales and Growth Rate (2015-2020)
11.6 Chile Age Related Macular Degeneration Biologic Drug Sales and Growth Rate (2015-2020)
12 Competitive Landscape
12.1 Regeneron
12.1.1 Regeneron Basic Information
12.1.2 Age Related Macular Degeneration Biologic Drug Product Introduction
12.1.3 Regeneron Production, Value, Price, Gross Margin 2015-2020
12.2 Valeant
12.2.1 Valeant Basic Information
12.2.2 Age Related Macular Degeneration Biologic Drug Product Introduction
12.2.3 Valeant Production, Value, Price, Gross Margin 2015-2020
12.3 Novartis
12.3.1 Novartis Basic Information
12.3.2 Age Related Macular Degeneration Biologic Drug Product Introduction
12.3.3 Novartis Production, Value, Price, Gross Margin 2015-2020
12.4 Genentech
12.4.1 Genentech Basic Information
12.4.2 Age Related Macular Degeneration Biologic Drug Product Introduction
12.4.3 Genentech Production, Value, Price, Gross Margin 2015-2020
12.5 Allergan
12.5.1 Allergan Basic Information
12.5.2 Age Related Macular Degeneration Biologic Drug Product Introduction
12.5.3 Allergan Production, Value, Price, Gross Margin 2015-2020
12.6 Eli Lilly
12.6.1 Eli Lilly Basic Information
12.6.2 Age Related Macular Degeneration Biologic Drug Product Introduction
12.6.3 Eli Lilly Production, Value, Price, Gross Margin 2015-2020
12.7 Alimera Sciences
12.7.1 Alimera Sciences Basic Information
12.7.2 Age Related Macular Degeneration Biologic Drug Product Introduction
12.7.3 Alimera Sciences Production, Value, Price, Gross Margin 2015-2020
12.8 Merck
12.8.1 Merck Basic Information
12.8.2 Age Related Macular Degeneration Biologic Drug Product Introduction
12.8.3 Merck Production, Value, Price, Gross Margin 2015-2020
12.9 Acucela
12.9.1 Acucela Basic Information
12.9.2 Age Related Macular Degeneration Biologic Drug Product Introduction
12.9.3 Acucela Production, Value, Price, Gross Margin 2015-2020
12.10 Bayer
12.10.1 Bayer Basic Information
12.10.2 Age Related Macular Degeneration Biologic Drug Product Introduction
12.10.3 Bayer Production, Value, Price, Gross Margin 2015-2020
12.11 Ophthotech Corporation
12.11.1 Ophthotech Corporation Basic Information
12.11.2 Age Related Macular Degeneration Biologic Drug Product Introduction
12.11.3 Ophthotech Corporation Production, Value, Price, Gross Margin 2015-2020
13 Industry Outlook
13.1 Market Driver Analysis
13.1.2 Market Restraints Analysis
13.1.3 Market Trends Analysis
13.2 Merger, Acquisition and New Investment
13.3 News of Product Release
14 Global Age Related Macular Degeneration Biologic Drug Market Forecast
14.1 Global Age Related Macular Degeneration Biologic Drug Market Value & Volume Forecast, by Type (2020-2025)
14.1.1 Ranibizumab Market Value and Volume Forecast (2020-2025)
14.1.2 Bevacizumab Market Value and Volume Forecast (2020-2025)
14.1.3 Aflibercept Market Value and Volume Forecast (2020-2025)
14.2 Global Age Related Macular Degeneration Biologic Drug Market Value & Volume Forecast, by Application (2020-2025)
14.2.1 Outpatient Surgery Center Market Value and Volume Forecast (2020-2025)
14.2.2 Eye Clinic Market Value and Volume Forecast (2020-2025)
14.2.3 Hospital Market Value and Volume Forecast (2020-2025)
14.3 Age Related Macular Degeneration Biologic Drug Market Analysis and Forecast by Region
14.3.1 North America Market Value and Consumption Forecast (2020-2025)
14.3.2 Europe Market Value and Consumption Forecast (2020-2025)
14.3.3 Asia Pacific Market Value and Consumption Forecast (2020-2025)
14.3.4 Middle East and Africa Market Value and Consumption Forecast (2020-2025)
14.3.5 South America Market Value and Consumption Forecast (2020-2025)
15 New Project Feasibility Analysis
15.1 Industry Barriers and New Entrants SWOT Analysis
15.1.1 Porter’s Five Forces Analysis
15.1.2 New Entrants SWOT Analysis
15.2 Analysis and Suggestions on New Project Investment
List of Tables and Figures
Figure Product Picture of Age Related Macular Degeneration Biologic Drug
Table Product Specification of Age Related Macular Degeneration Biologic Drug
Table Age Related Macular Degeneration Biologic Drug Key Market Segments
Table Key Players Age Related Macular Degeneration Biologic Drug Covered
Figure Global Age Related Macular Degeneration Biologic Drug Market Size, 2015 – 2025
Table Different Types of Age Related Macular Degeneration Biologic Drug
Figure Global Age Related Macular Degeneration Biologic Drug Value ($) Segment by Type from 2015-2020
Figure Global Age Related Macular Degeneration Biologic Drug Market Share by Types in 2019
Table Different Applications of Age Related Macular Degeneration Biologic Drug
Figure Global Age Related Macular Degeneration Biologic Drug Value ($) Segment by Applications from 2015-2020
Figure Global Age Related Macular Degeneration Biologic Drug Market Share by Applications in 2019
Figure Global Age Related Macular Degeneration Biologic Drug Market Share by Regions in 2019
Figure North America Age Related Macular Degeneration Biologic Drug Production Value ($) and Growth Rate (2015-2020)
Figure Europe Age Related Macular Degeneration Biologic Drug Production Value ($) and Growth Rate (2015-2020)
Figure Asia Pacific Age Related Macular Degeneration Biologic Drug Production Value ($) and Growth Rate (2015-2020)
Figure Middle East and Africa Age Related Macular Degeneration Biologic Drug Production Value ($) and Growth Rate (2015-2020)
Figure South America Age Related Macular Degeneration Biologic Drug Production Value ($) and Growth Rate (2015-2020)
Table Global COVID-19 Status and Economic Overview
Figure Global COVID-19 Status
Figure COVID-19 Comparison of Major Countries
Figure Industry Chain Analysis of Age Related Macular Degeneration Biologic Drug
Table Upstream Raw Material Suppliers of Age Related Macular Degeneration Biologic Drug with Contact Information
Table Major Players Headquarters, and Service Area of Age Related Macular Degeneration Biologic Drug
Figure Major Players Production Value Market Share of Age Related Macular Degeneration Biologic Drug in 2019
Table Major Players Age Related Macular Degeneration Biologic Drug Product Types in 2019
Figure Production Process of Age Related Macular Degeneration Biologic Drug
Figure Manufacturing Cost Structure of Age Related Macular Degeneration Biologic Drug
Figure Channel Status of Age Related Macular Degeneration Biologic Drug
Table Major Distributors of Age Related Macular Degeneration Biologic Drug with Contact Information
Table Major Downstream Buyers of Age Related Macular Degeneration Biologic Drug with Contact Information
Table Global Age Related Macular Degeneration Biologic Drug Value ($) by Type (2015-2020)
Table Global Age Related Macular Degeneration Biologic Drug Value Share by Type (2015-2020)
Figure Global Age Related Macular Degeneration Biologic Drug Value Share by Type (2015-2020)
Table Global Age Related Macular Degeneration Biologic Drug Production by Type (2015-2020)
Table Global Age Related Macular Degeneration Biologic Drug Production Share by Type (2015-2020)
Figure Global Age Related Macular Degeneration Biologic Drug Production Share by Type (2015-2020)
Figure Global Age Related Macular Degeneration Biologic Drug Value ($) and Growth Rate of Ranibizumab (2015-2020)
Figure Global Age Related Macular Degeneration Biologic Drug Value ($) and Growth Rate of Bevacizumab (2015-2020)
Figure Global Age Related Macular Degeneration Biologic Drug Value ($) and Growth Rate of Aflibercept (2015-2020)
Figure Global Age Related Macular Degeneration Biologic Drug Price by Type (2015-2020)
Figure Downstream Market Overview
Table Global Age Related Macular Degeneration Biologic Drug Consumption by Application (2015-2020)
Table Global Age Related Macular Degeneration Biologic Drug Consumption Market Share by Application (2015-2020)
Figure Global Age Related Macular Degeneration Biologic Drug Consumption Market Share by Application (2015-2020)
Figure Global Age Related Macular Degeneration Biologic Drug Consumption and Growth Rate of Outpatient Surgery Center (2015-2020)
Figure Global Age Related Macular Degeneration Biologic Drug Consumption and Growth Rate of Eye Clinic (2015-2020)
Figure Global Age Related Macular Degeneration Biologic Drug Consumption and Growth Rate of Hospital (2015-2020)
Figure Global Age Related Macular Degeneration Biologic Drug Sales and Growth Rate (2015-2020)
Figure Global Age Related Macular Degeneration Biologic Drug Revenue (M USD) and Growth (2015-2020)
Table Global Age Related Macular Degeneration Biologic Drug Sales by Regions (2015-2020)
Table Global Age Related Macular Degeneration Biologic Drug Sales Market Share by Regions (2015-2020)
Table Global Age Related Macular Degeneration Biologic Drug Revenue (M USD) by Regions (2015-2020)
Table Global Age Related Macular Degeneration Biologic Drug Revenue Market Share by Regions (2015-2020)
Table Global Age Related Macular Degeneration Biologic Drug Revenue Market Share by Regions in 2015
Table Global Age Related Macular Degeneration Biologic Drug Revenue Market Share by Regions in 2019
Figure North America Age Related Macular Degeneration Biologic Drug Sales and Growth Rate (2015-2020)
Figure Europe Age Related Macular Degeneration Biologic Drug Sales and Growth Rate (2015-2020)
Figure Asia-Pacific Age Related Macular Degeneration Biologic Drug Sales and Growth Rate (2015-2020)
Figure Middle East and Africa Age Related Macular Degeneration Biologic Drug Sales and Growth Rate (2015-2020)
Figure South America Age Related Macular Degeneration Biologic Drug Sales and Growth Rate (2015-2020)
Figure North America COVID-19 Status
Figure North America COVID-19 Confirmed Cases Major Distribution
Figure North America Age Related Macular Degeneration Biologic Drug Revenue (M USD) and Growth (2015-2020)
Table North America Age Related Macular Degeneration Biologic Drug Sales by Countries (2015-2020)
Table North America Age Related Macular Degeneration Biologic Drug Sales Market Share by Countries (2015-2020)
Table North America Age Related Macular Degeneration Biologic Drug Revenue (M USD) by Countries (2015-2020)
Table North America Age Related Macular Degeneration Biologic Drug Revenue Market Share by Countries (2015-2020)
Figure United States Age Related Macular Degeneration Biologic Drug Sales and Growth Rate (2015-2020)
Figure Canada Age Related Macular Degeneration Biologic Drug Sales and Growth Rate (2015-2020)
Figure Mexico Age Related Macular Degeneration Biologic Drug Sales and Growth (2015-2020)
Figure Europe COVID-19 Status
Figure Europe COVID-19 Confirmed Cases Major Distribution
Figure Europe Age Related Macular Degeneration Biologic Drug Revenue (M USD) and Growth (2015-2020)
Table Europe Age Related Macular Degeneration Biologic Drug Sales by Countries (2015-2020)
Table Europe Age Related Macular Degeneration Biologic Drug Sales Market Share by Countries (2015-2020)
Table Europe Age Related Macular Degeneration Biologic Drug Revenue (M USD) by Countries (2015-2020)
Table Europe Age Related Macular Degeneration Biologic Drug Revenue Market Share by Countries (2015-2020)
Figure Germany Age Related Macular Degeneration Biologic Drug Sales and Growth Rate (2015-2020)
Figure UK Age Related Macular Degeneration Biologic Drug Sales and Growth Rate (2015-2020)
Figure France Age Related Macular Degeneration Biologic Drug Sales and Growth (2015-2020)
Figure Italy Age Related Macular Degeneration Biologic Drug Sales and Growth (2015-2020)
Figure Spain Age Related Macular Degeneration Biologic Drug Sales and Growth (2015-2020)
Figure Russia Age Related Macular Degeneration Biologic Drug Sales and Growth (2015-2020)
Figure Asia Pacific COVID-19 Status
Figure Asia Pacific Age Related Macular Degeneration Biologic Drug Revenue (M USD) and Growth (2015-2020)
Table Asia Pacific Age Related Macular Degeneration Biologic Drug Sales by Countries (2015-2020)
Table Asia Pacific Age Related Macular Degeneration Biologic Drug Sales Market Share by Countries (2015-2020)
Table Asia Pacific Age Related Macular Degeneration Biologic Drug Revenue (M USD) by Countries (2015-2020)
Table Asia Pacific Age Related Macular Degeneration Biologic Drug Revenue Market Share by Countries (2015-2020)
Figure China Age Related Macular Degeneration Biologic Drug Sales and Growth Rate (2015-2020)
Figure Japan Age Related Macular Degeneration Biologic Drug Sales and Growth Rate (2015-2020)
Figure South Korea Age Related Macular Degeneration Biologic Drug Sales and Growth (2015-2020)
Figure India Age Related Macular Degeneration Biologic Drug Sales and Growth (2015-2020)
Figure Southeast Asia Age Related Macular Degeneration Biologic Drug Sales and Growth (2015-2020)
Figure Australia Age Related Macular Degeneration Biologic Drug Sales and Growth (2015-2020)
Figure Middle East Age Related Macular Degeneration Biologic Drug Revenue (M USD) and Growth (2015-2020)
Table Middle East Age Related Macular Degeneration Biologic Drug Sales by Countries (2015-2020)
Table Middle East and Africa Age Related Macular Degeneration Biologic Drug Sales Market Share by Countries (2015-2020)
Table Middle East and Africa Age Related Macular Degeneration Biologic Drug Revenue (M USD) by Countries (2015-2020)
Table Middle East and Africa Age Related Macular Degeneration Biologic Drug Revenue Market Share by Countries (2015-2020)
Figure Saudi Arabia Age Related Macular Degeneration Biologic Drug Sales and Growth Rate (2015-2020)
Figure UAE Age Related Macular Degeneration Biologic Drug Sales and Growth Rate (2015-2020)
Figure Egypt Age Related Macular Degeneration Biologic Drug Sales and Growth (2015-2020)
Figure Nigeria Age Related Macular Degeneration Biologic Drug Sales and Growth (2015-2020)
Figure South Africa Age Related Macular Degeneration Biologic Drug Sales and Growth (2015-2020)
Figure South America Age Related Macular Degeneration Biologic Drug Revenue (M USD) and Growth (2015-2020)
Table South America Age Related Macular Degeneration Biologic Drug Sales by Countries (2015-2020)
Table South America Age Related Macular Degeneration Biologic Drug Sales Market Share by Countries (2015-2020)
Table South America Age Related Macular Degeneration Biologic Drug Revenue (M USD) by Countries (2015-2020)
Table South America Age Related Macular Degeneration Biologic Drug Revenue Market Share by Countries (2015-2020)
Figure Brazil Age Related Macular Degeneration Biologic Drug Sales and Growth Rate (2015-2020)
Figure Argentina Age Related Macular Degeneration Biologic Drug Sales and Growth Rate (2015-2020)
Figure Columbia Age Related Macular Degeneration Biologic Drug Sales and Growth (2015-2020)
Figure Chile Age Related Macular Degeneration Biologic Drug Sales and Growth (2015-2020)
Figure Top 3 Market Share of Age Related Macular Degeneration Biologic Drug Companies in 2019
Figure Top 6 Market Share of Age Related Macular Degeneration Biologic Drug Companies in 2019
Table Major Players Production Value ($) Share (2015-2020)
Table Regeneron Profile
Table Regeneron Product Introduction
Figure Regeneron Production and Growth Rate
Figure Regeneron Value ($) Market Share 2015-2020
Table Valeant Profile
Table Valeant Product Introduction
Figure Valeant Production and Growth Rate
Figure Valeant Value ($) Market Share 2015-2020
Table Novartis Profile
Table Novartis Product Introduction
Figure Novartis Production and Growth Rate
Figure Novartis Value ($) Market Share 2015-2020
Table Genentech Profile
Table Genentech Product Introduction
Figure Genentech Production and Growth Rate
Figure Genentech Value ($) Market Share 2015-2020
Table Allergan Profile
Table Allergan Product Introduction
Figure Allergan Production and Growth Rate
Figure Allergan Value ($) Market Share 2015-2020
Table Eli Lilly Profile
Table Eli Lilly Product Introduction
Figure Eli Lilly Production and Growth Rate
Figure Eli Lilly Value ($) Market Share 2015-2020
Table Alimera Sciences Profile
Table Alimera Sciences Product Introduction
Figure Alimera Sciences Production and Growth Rate
Figure Alimera Sciences Value ($) Market Share 2015-2020
Table Merck Profile
Table Merck Product Introduction
Figure Merck Production and Growth Rate
Figure Merck Value ($) Market Share 2015-2020
Table Acucela Profile
Table Acucela Product Introduction
Figure Acucela Production and Growth Rate
Figure Acucela Value ($) Market Share 2015-2020
Table Bayer Profile
Table Bayer Product Introduction
Figure Bayer Production and Growth Rate
Figure Bayer Value ($) Market Share 2015-2020
Table Ophthotech Corporation Profile
Table Ophthotech Corporation Product Introduction
Figure Ophthotech Corporation Production and Growth Rate
Figure Ophthotech Corporation Value ($) Market Share 2015-2020
Table Market Driving Factors of Age Related Macular Degeneration Biologic Drug
Table Merger, Acquisition and New Investment
Table Global Age Related Macular Degeneration Biologic Drug Market Value ($) Forecast, by Type
Table Global Age Related Macular Degeneration Biologic Drug Market Volume Forecast, by Type
Figure Global Age Related Macular Degeneration Biologic Drug Market Value ($) and Growth Rate Forecast of Ranibizumab (2020-2025)
Figure Global Age Related Macular Degeneration Biologic Drug Market Volume ($) and Growth Rate Forecast of Ranibizumab (2020-2025)
Figure Global Age Related Macular Degeneration Biologic Drug Market Value ($) and Growth Rate Forecast of Bevacizumab (2020-2025)
Figure Global Age Related Macular Degeneration Biologic Drug Market Volume ($) and Growth Rate Forecast of Bevacizumab (2020-2025)
Figure Global Age Related Macular Degeneration Biologic Drug Market Value ($) and Growth Rate Forecast of Aflibercept (2020-2025)
Figure Global Age Related Macular Degeneration Biologic Drug Market Volume ($) and Growth Rate Forecast of Aflibercept (2020-2025)
Table Global Market Value ($) Forecast by Application (2020-2025)
Table Global Market Volume Forecast by Application (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of Outpatient Surgery Center (2020-2025)
Figure Market Volume and Growth Rate Forecast of Outpatient Surgery Center (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of Eye Clinic (2020-2025)
Figure Market Volume and Growth Rate Forecast of Eye Clinic (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of Hospital (2020-2025)
Figure Market Volume and Growth Rate Forecast of Hospital (2020-2025)
Figure North America Market Value ($) and Growth Rate Forecast (2020-2025)
Figure North America Consumption and Growth Rate Forecast (2020-2025)
Figure Europe Market Value ($) and Growth Rate Forecast (2020-2025)
Figure Europe Consumption and Growth Rate Forecast (2020-2025)
Figure Asia Pacific Market Value ($) and Growth Rate Forecast (2020-2025)
Figure Asia Pacific Consumption and Growth Rate Forecast (2020-2025)
Figure Middle East and Africa Market Value ($) and Growth Rate Forecast (2020-2025)
Figure Middle East and Africa Consumption and Growth Rate Forecast (2020-2025)
Figure South America Market Value ($) and Growth Rate Forecast (2020-2025)
Figure South America Consumption and Growth Rate Forecast (2020-2025)
Figure Porter’s Five Forces Analysis
Table New Entrants SWOT Analysis
Table New Project Analysis of Investment Recovery
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
